This most current twist during the Lykos Therapeutics saga threatens A significant overhaul of the business’s strategy and path, with Musk ally and billionaire investor Antonio Gracias showing to would like to choose the company back again toward its nonprofit drug improvement roots and a far more Doblinite philosophy.Patent apps are mystery for